EMEA-001039-PIP01-10-M02

Key facts

Invented name
  • Xeomin
  • Bocouture
Active substance
Clostridium botulinum neurotoxin type A (150 kD), free of complexing proteins
Therapeutic area
Neurology
Decision number
P/0157/2016
PIP number
EMEA-001039-PIP01-10-M02
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
  • Treatment of muscle-induced wrinkles
  • Treatment of dystonia
  • Treatment of muscle spasticity
Route(s) of administration
intramuscular use
Contact for public enquiries
Merz Pharmaceuticals GmbH 
Germany
Tel. +49 6915031 
Fax +49 691503200
E-mail: contact@merz.de
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001039-PIP01-10-M02
Compliance opinion date
15/12/2017
Compliance outcome
positive

Decision

How useful was this page?

Add your rating